Actively Recruiting
Study of Urinary Excretion Patterns of Gadolinium Contrast Agents in MRI Patients to Explore Recovery Protocols
Led by Centre Hospitalier Régional Metz-Thionville · Updated on 2026-08-21
60
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research investigates the urinary excretion patterns of gadolinium-based contrast agents Gd-CAs used in magnetic resonance imaging MRI. Gadolinium, a rare earth element, is toxic in its isolated form but is safely used in complex molecules as contrast agents to enhance MRI images. The study aims to understand how these agents are eliminated through urine shortly after MRI and explores the potential for recovering gadolinium from urine to reduce environmental contamination. Participants prescribed MRI scans with gadolinium contrast agents will have urine samples collected before the injection and multiple times within two and a half hours after receiving the contrast agent. Blood samples are also collected before injection to assess renal function. This single-group study focuses on describing the elimination kinetics of gadolinium contrast agents via urine following MRI. Participants will provide blood and urine samples around the time of their MRI scan. Researchers will monitor urinary excretion of gadolinium at two and a half hours post-injection and measure factors such as renal function, beverage intake volume, and timing of the first spontaneous urination. The study also tracks refusal rates and premature exits. Participation involves sample collections at the MRI visit, with total study duration centered on the immediate post-injection period.
CONDITIONS
Brief Title
Kinetics of Urinary Excretion of Gadolinium Contrast Agents Used in MRI Examinations
Research Team
A
Arpiné EL NAR, PhD
M
Mélanie JUNKE
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here